2013 Annual Meeting | Hot Topics Plenary Session
05:15 PM - 05:30 PM |
Rare and Common Genetic Risk Factors for Alzheimer’s Disease
Alison Goate, PhD |
|
05:30 PM - 05:45 PM |
Fungal Meningitis Outbreak: 2012
David B. Clifford, MD, FAAN |
|
05:45 PM - 06:00 PM |
Synthetic Tau Fibrils Mediate Transmission of Neurofibrillary Tangles in a Transgenic Mouse Model of Alzheimer’s-like Tauopathy
John Q. Trojanowski, MD, PhD |
|
06:00 PM - 06:15 PM |
Radiation-induced Memory Dysfunction: Neural Stem Cell Etiology and Emerging Therapies
Michelle Monje, MD, PhD, FAAN |
Michelle Monje, MD, PhD, FAAN | An immediate family member of Dr. Monje has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for MapLight Therapeutics . An immediate family member of Dr. Monje has stock in MapLight Therapeutics . |
Alison Goate, PhD | No disclosure on file |
John Q. Trojanowski, MD, PhD | Dr. Trojanowski has nothing to disclose. |
David B. Clifford, MD, FAAN | Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Excision BioTherapeutics. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Seagen. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CellEvolve. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Wave Life Sciences. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atara Biotherapeuitics. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arena Pharmaceuticals. Dr. Clifford has received publishing royalties from a publication relating to health care. |